Gluten Labeling 2026: FDA’s New RFI and What Celiacs Need

You shouldn’t need a law degree and a bloodhound nose to buy crackers safely. But here we are. On January 21, 2026, the FDA announced a new Request for Information (RFI) on gluten labeling and cross-contact in packaged foods, and my inbox immediately filled with the same question: “Is anything actually changing, or is this just more government theater?”

The Verdict: This is not the finish line, but it is a real opening. If we use it right, we can force better transparency on barley/rye ingredients, cross-contact language, and the label loopholes that keep glutening people who are doing everything “right.”

If you’re Celiac, this matters now, not later.

Jump to Action Protocol

The 5-Minute Pantry Audit
How to File a Real Complaint (That Gets Read)
The 3 Label Red Flags to Stop Ignoring
What to Say to Brands When You Email Them

Why This Matters Right Now

The old FDA gluten-free framework is still in place: a product labeled “gluten-free” must be under 20 ppm and can’t intentionally include unprocessed wheat, barley, or rye ingredients. That part didn’t vanish overnight.

What changed in 2026 is the pressure point. FDA is explicitly asking for data and experiences around non-wheat gluten grains (barley and rye) plus oat cross-contact and how these ingredients are disclosed on labels. That is exactly where people keep getting burned.

Listen, legal compliance and real-world safety are not the same thing. We’ve all seen labels that are technically legal and practically useless.

(And yes, “gluten-friendly” is still code for “we’re hoping you don’t ask follow-up questions.”)

The Before Times vs. The Label Maze

In The Before Times, you grabbed a box, checked price, moved on with your life. Post-diagnosis, you’re reading ingredient lists like they’re legal contracts written during a power outage.

The problem isn’t just “contains wheat.” That one is obvious. The problem is everything hiding in the gray zone:

barley-based ingredients that aren’t front-and-center
inconsistent cross-contact disclosures
oat products with vague sourcing language
brands that slap on lifestyle messaging but won’t publish testing standards

If you’ve been glutened while eating “carefully,” you are not failing at Celiac. The system is under-disclosing risk.

What FDA’s January 21, 2026 Move Actually Means

Here’s the plain-English version.

1. The FDA is collecting evidence, not issuing a final new rule yet

An RFI is a formal “show us what’s happening” step. It’s how agencies build a regulatory record before they propose or change rules.

Translation: this is your window to submit concrete examples while the door is open.

2. Barley, rye, and oat cross-contact are finally centered

This matters because too many incidents sit in the gap between obvious wheat labeling and subtle gluten risk. If future guidance gets tighter on disclosure, shopping gets less like roulette.

3. Complaint logistics have changed since 2024

The FDA’s Human Foods Program centralized complaint intake. If you’re still using old pathways, your report may never land where it needs to go. The current route is the Safety Reporting Portal / Human Foods complaint channels.

The 3 Label Red Flags I’m Seeing Constantly

Red Flag #1: “Gluten-free” claim plus murky malt language

If a product or related brand materials mention malt and can’t identify source grain clearly, that’s a stop sign until clarified. Barley-derived ingredients are still a major trap.

Red Flag #2: Oat product with no process transparency

“Made with gluten-free oats” is not enough for high-risk people if there’s no detail on sourcing, separation, and testing cadence. Oats can be safe, but only when the supply chain is actually controlled.

Red Flag #3: Vibe words instead of safety words

“Craft,” “wholesome,” “better-for-you,” “ancient grains,” all very cute. None of that tells me whether your line is shared with wheat flour.

Mouthfeel matters. Maillard reaction matters. Flavor matters. But none of it matters if the food is unsafe.

The 5-Minute Pantry Audit (Do This Tonight)

Open your pantry. Timer on. No overthinking.

Pull every product with oats, malt, “natural flavors,” seasoning blends, or hydrolyzed proteins.
Separate into three piles: clearly safe, needs verification, hard no.
For needs verification, take photos of ingredient panel + lot code.
Email the brand using the script below.
If you had a reaction, file a complaint with FDA Human Foods channels the same day while details are fresh.

You’re building your own traceability system because brands still won’t do enough of it for you.

Brand Email Script (Copy/Paste)

Use this and make them answer specifics:

I have celiac disease and need clarification before purchasing again.

Are barley, rye, or oat-derived ingredients used in this specific product?

Is this product made on shared equipment with wheat, barley, or rye?

What gluten test method and threshold do you use for final product release?

Do you perform lot-specific testing, and can you share the most recent result range?

If they reply with marketing copy instead of process detail, that’s your answer.

How to File a Useful FDA Complaint

Don’t send “this made me feel bad” and hope for magic. Send structured data.

Include:

product name, size, UPC
lot code and best-by date
where you bought it and when
photo of full label (ingredients + allergen statement)
symptom timing (for example: 2 hours, 8 hours, next morning)
whether the item was labeled gluten-free

Listen, regulators can’t act on vibes either. Give them patterns they can investigate.

The Texture Lab Angle Nobody Talks About

Everyone frames this like a labeling-only issue. It’s also a product-development issue.

When brands remove wheat structure, they often overcorrect with rice starch and gums, then hide behind a “gluten-free” badge while quality tanks. You get two failures at once:

safety ambiguity
texture collapse

The community keeps paying the GF Tax for food with no chew, no spring, no dignity.

If you’re charging premium prices, you owe us two things: verified safety and competent crumb.

What You Should Expect Next (Realistically)

Short term: more public comments, more advocacy pressure, and more spotlight on barley/rye/oat disclosure gaps.

Medium term: likely guidance updates and possibly stronger disclosure expectations around cross-contact contexts.

Long term: if enough high-quality reports stack up, the agency has a stronger basis for meaningful enforcement and policy tightening.

No, this won’t be fixed by next Tuesday. But this is one of the few moments where patient data can directly shape the rules.

Takeaway: Don’t Wait for Perfect Labels

Do the pantry audit. Ask hard questions. File clean complaints when something goes wrong. Keep receipts, lot codes, and screenshots like you’re building a case file, because you are.

For the full field protocol on oat reactions and controlled reintroduction, read my oat audit breakdown here: Certified Gluten-Free Oats: Why They Still Gluten You in 2026.

And if you want the kitchen side of this fight, my flour showdown is here: Brand Showdown: The 1-to-1 Flour Lie.

You’re not “being difficult.” You’re running medical-grade risk management in a food system that still prefers vague language.

Stay safe, eat well.

Excerpt (157 chars): FDA’s January 2026 gluten labeling RFI could reshape barley, rye, and oat cross-contact transparency. Here’s the pantry audit and complaint playbook.

Tags: gluten labeling 2026, celiac safety, cross-contact, FDA Human Foods Program, gluten-free advocacy